Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01751776
Recruitment Status : Completed
First Posted : December 18, 2012
Last Update Posted : May 12, 2015
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2015
  Study Completion Date : April 2015